BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Honda-Okubo Y, Kolpe A, Li L, Petrovsky N. A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection. Vaccine 2014;32:4651-9. [PMID: 24958701 DOI: 10.1016/j.vaccine.2014.06.057] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Massarali A, Adhya D, Srivastava DP, Baron-cohen S, Kotter MR. Virus-Induced Maternal Immune Activation as an Environmental Factor in the Etiology of Autism and Schizophrenia. Front Neurosci 2022;16:834058. [DOI: 10.3389/fnins.2022.834058] [Reference Citation Analysis]
2 Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WL. Inulin, a flexible oligosaccharide. II: Review of its pharmaceutical applications. Carbohydrate Polymers 2015;134:418-28. [DOI: 10.1016/j.carbpol.2015.08.022] [Cited by in Crossref: 75] [Cited by in F6Publishing: 57] [Article Influence: 10.7] [Reference Citation Analysis]
3 Petroski N. Advax Adjuvant. Immunopotentiators in Modern Vaccines. Elsevier; 2017. pp. 199-210. [DOI: 10.1016/b978-0-12-804019-5.00010-4] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Tabarsi P, Anjidani N, Shahpari R, Mardani M, Sabzvari A, Yazdani B, Roshanzamir K, Bayatani B, Taheri A, Petrovsky N, Li L, Barati S. Safety and immunogenicity of SpikoGen®, an advax-cpg55.2-adjuvanted sars-cov-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Sakala IG, Honda-Okubo Y, Li L, Baldwin J, Petrovsky N. A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization. Vaccine 2021;39:5162-72. [PMID: 34362601 DOI: 10.1016/j.vaccine.2021.07.037] [Reference Citation Analysis]
6 Fanhchaksai K, Kodchakorn K, Pothacharoen P, Kongtawelert P. Effect of sesamin against cytokine production from influenza type A H1N1-induced peripheral blood mononuclear cells: computational and experimental studies. In Vitro Cell Dev Biol Anim 2016;52:107-19. [PMID: 26424131 DOI: 10.1007/s11626-015-9950-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
7 Heddle R, Smith A, Woodman R, Hissaria P, Petrovsky N. Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy. J Allergy Clin Immunol 2019;144:504-513.e16. [PMID: 31300280 DOI: 10.1016/j.jaci.2019.03.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
8 Saso A, Kampmann B. Maternal Immunization: Nature Meets Nurture. Front Microbiol 2020;11:1499. [PMID: 32849319 DOI: 10.3389/fmicb.2020.01499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Barclay T, Petrovsky N. Vaccine Adjuvant Nanotechnologies. Micro and Nanotechnology in Vaccine Development. Elsevier; 2017. pp. 127-47. [DOI: 10.1016/b978-0-323-39981-4.00007-5] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Stronsky SM, Cooper CL, Steffens J, Van Tongeren S, Bavari S, Martins KA, Petrovsky N. Adjuvant selection impacts the correlates of vaccine protection against Ebola infection. Vaccine 2020;38:4601-8. [PMID: 32418798 DOI: 10.1016/j.vaccine.2020.05.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 de Paula Oliveira Santos B, Trentini MM, Machado RB, Rúbia Nunes Celes M, Kipnis A, Petrovsky N, Junqueira-Kipnis AP. Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of four protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection. Hum Vaccin Immunother 2017;13:2967-76. [PMID: 28937879 DOI: 10.1080/21645515.2017.1368598] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
12 McPherson C, Chubet R, Holtz K, Honda-Okubo Y, Barnard D, Cox M, Petrovsky N. Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant. Methods Mol Biol 2016;1403:269-84. [PMID: 27076136 DOI: 10.1007/978-1-4939-3387-7_14] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
13 Li L, Honda-Okubo Y, Li C, Sajkov D, Petrovsky N. Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine. PLoS One 2015;10:e0132003. [PMID: 26177480 DOI: 10.1371/journal.pone.0132003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
14 Honda-Okubo Y, Rajapaksha H, Sajkov D, Gordon D, Cox MMJ, Petrovsky N. Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine. Hum Vaccin Immunother 2017;13:1-11. [PMID: 28301280 DOI: 10.1080/21645515.2017.1279765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Menon V, Ayala VI, Rangaswamy SP, Kalisz I, Whitney S, Galmin L, Ashraf A, LaBranche C, Montefiori D, Petrovsky N, Kalyanaraman VS, Pal R. DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant. J Gen Virol 2017;98:2143-55. [PMID: 28758637 DOI: 10.1099/jgv.0.000863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Frew PM, Owens LE, Saint-Victor DS, Benedict S, Zhang S, Omer SB. Factors associated with maternal influenza immunization decision-making. Evidence of immunization history and message framing effects. Hum Vaccin Immunother 2014;10:2576-83. [PMID: 25483468 DOI: 10.4161/hv.32248] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
17 Luczo JM, Bousse T, Johnson SK, Jones CA, Pearce N, Neiswanger CA, Wang MX, Miller EA, Petrovsky N, Wentworth DE, Bronshtein V, Papania M, Tompkins SM. Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets. NPJ Vaccines 2021;6:59. [PMID: 33883559 DOI: 10.1038/s41541-021-00320-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Barclay TG, Rajapaksha H, Thilagam A, Qian G, Ginic-Markovic M, Cooper PD, Gerson A, Petrovsky N. Physical characterization and in silico modeling of inulin polymer conformation during vaccine adjuvant particle formation. Carbohydr Polym 2016;143:108-15. [PMID: 27083349 DOI: 10.1016/j.carbpol.2016.01.062] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
19 Brillo E, Tosto V, Giardina I, Buonomo E. Maternal tetanus, diphtheria, and acellular pertussis (Tdap) and influenza immunization: an overview. J Matern Fetal Neonatal Med 2021;34:3415-44. [PMID: 31645152 DOI: 10.1080/14767058.2019.1680633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
20 Calderon-Gonzalez R, Tobes R, Pareja E, Frande-Cabanes E, Petrovsky N, Alvarez-Dominguez C. Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines. J Immunol Methods 2015;424:111-9. [PMID: 26031451 DOI: 10.1016/j.jim.2015.05.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
21 Barclay TG, Day CM, Petrovsky N, Garg S. Review of polysaccharide particle-based functional drug delivery. Carbohydr Polym 2019;221:94-112. [PMID: 31227171 DOI: 10.1016/j.carbpol.2019.05.067] [Cited by in Crossref: 79] [Cited by in F6Publishing: 54] [Article Influence: 26.3] [Reference Citation Analysis]
22 Wüthrich M, Dobson HE, Ledesma Taira C, Okaa UJ, Dos Santos Dias L, Isidoro-Ayza M, Petrovsky N, Klein BS. Combination Adjuvants Enhance Recombinant Protein Vaccine Protection against Fungal Infection. mBio 2021;12:e0201821. [PMID: 34399628 DOI: 10.1128/mBio.02018-21] [Reference Citation Analysis]
23 Rodriguez-Del Rio E, Marradi M, Calderon-Gonzalez R, Frande-Cabanes E, Penadés S, Petrovsky N, Alvarez-Dominguez C. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection. Vaccine 2015;33:1465-73. [PMID: 25659269 DOI: 10.1016/j.vaccine.2015.01.062] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 8.3] [Reference Citation Analysis]
24 Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG, Petrovsky N. Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant. Vaccine 2016;34:3780-6. [PMID: 27342914 DOI: 10.1016/j.vaccine.2016.05.071] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
25 Petrovsky N, Cooper PD. Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety. Vaccine 2015;33:5920-6. [PMID: 26407920 DOI: 10.1016/j.vaccine.2015.09.030] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
26 Cattane N, Richetto J, Cattaneo A. Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms. Neurosci Biobehav Rev 2020;117:253-78. [PMID: 29981347 DOI: 10.1016/j.neubiorev.2018.07.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
27 Honda-Okubo Y, Ong CH, Petrovsky N. Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection. Vaccine 2015;33:4892-900. [PMID: 26232344 DOI: 10.1016/j.vaccine.2015.07.051] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
28 Sakala IG, Honda-Okubo Y, Fung J, Petrovsky N. Influenza immunization during pregnancy: Benefits for mother and infant. Hum Vaccin Immunother 2016;12:3065-71. [PMID: 27494630 DOI: 10.1080/21645515.2016.1215392] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
29 Petrovsky N. Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs. Drug Saf 2015;38:1059-74. [PMID: 26446142 DOI: 10.1007/s40264-015-0350-4] [Cited by in Crossref: 128] [Cited by in F6Publishing: 124] [Article Influence: 21.3] [Reference Citation Analysis]
30 Honce R, Wohlgemuth N, Meliopoulos VA, Short KR, Schultz-Cherry S. Influenza in High-Risk Hosts-Lessons Learned from Animal Models. Cold Spring Harb Perspect Med 2020;10:a038604. [PMID: 31871227 DOI: 10.1101/cshperspect.a038604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Russell RF, McDonald JU, Lambert L, Tregoning JS. Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice. J Virol 2016;90:4735-44. [PMID: 26912628 DOI: 10.1128/JVI.03159-15] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
32 Honda-Okubo Y, Baldwin J, Petrovsky N. Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines. Pathogens 2021;10:500. [PMID: 33919442 DOI: 10.3390/pathogens10050500] [Reference Citation Analysis]